跳至主要内容
临床试验/ACTRN12615001106527
ACTRN12615001106527进行中(未招募)未知

Incidence of chemotherapy-induced alopecia (CIA) in breast cancer patients: effectiveness of two temperature levels of scalp cooling on reducing incidence of CIA

Breast Cancer Research Centre of Western Australia0 个研究点目标入组 63 人开始时间: 2015年10月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • histologically confirmed invasive breast cancer
  • - suitable to receive one of the approved chemotherapy regiments, defined in the protocol, in the neo/adjuvant or metastatic setting
  • - minimum understanding of English language to complete quality of life questionnaire
  • - willingness to be followed for 10 years

排除标准

  • - history of malignant primary brain tumour
  • - history of scalp or brain metastasis
  • - recommended chemotherapy given on weekly schedule
  • - patient suffering from cold sensitivity, cold agglutinin disease, cryoglobulinemia, cryofibrogenemia or cold traumatic dystrophy
  • - prior chemotherapy for any reason
  • - allergy to silicon
  • - concurrent treatment affecting hair growth

研究者

发起方
Breast Cancer Research Centre of Western Australia

相似试验